| 1 |
β thalassemia homozygous |
3 |
86.5 ± 1.3 |
4.09 ± 0.68 |
|
|
87.43 ± 5.27 |
| 2 |
β thalassemia trait |
25 |
0.9 ± 0.7 |
5.2 ± 0.74 |
|
|
1.09 ± 0.9 |
| 3 |
HbE β thalassemia |
5 |
19.1 ± 8.5 |
8.2 ± 2.2 |
51.0 ± 3.4 HbE (RT 2.67 min) |
|
17.34 ± 7.8 |
| 4 |
HbE heterozygous |
20 |
0.8 ± 0.3 |
3.9 ± 0.4 |
22.4 ± 1.5 HbE (RT 2.67 min) |
|
0.83 ± 0.5 |
| 5 |
HbE homozygous |
8 |
2.7 ± 1.2 |
7 ± 0.79 |
71.4 ± 4.1 HbE (RT 2.67 min) |
|
3.08 ± 1.49 |
| 6 |
HbD Punjab Heterozygous |
11 |
0.7 ± 0.8 |
2.7 ± 0.49 |
32.15 ± 4.3 HbD (RT 2.82 –2.84 min) |
|
0.918 ± 1.01 |
| 7 |
HbD Punjab homozygous |
2 |
1.3 ± 1.4 |
5.4 ± 2.12 |
77.4 ± 0.6 HbD (RT 2.82 –2.84 min) |
|
1.85 ± 1.9 |
| 8 |
HbDS Compound heterozygous |
2 |
37.1 ± 0 |
1.6 ± 0 |
33.9 ± 0 HbD (RT 2.82 –2.84 min) |
13.7 HbS (RT 3.11–3.16 min) |
40.2 |
| 9 |
HbS heterozygous |
12 |
1.02 ± 1.002 |
2.93 ± 0.67 |
26.8 ± 4.18 HbS (RT 3.11–3.16 min) |
|
1.208 ± 1.18 |
| 10 |
HbS homozygous |
8 |
18.48 ± 5.12 |
3.3 ± 1.4 |
61.6 ± 5.6 HbS (RT 3.11–3.16 min) |
|
17.3 ± 4.6 |
| 11 |
HbSβ thalassemia |
1 |
10.9 |
7.7 |
67.2 HbS (RT 3.11–3.16 min) |
|
10.2 |
| 12 |
HbQ |
2 |
0.37 ± 0.4 |
1.43 ± 0.09 |
12.0 ± 0.9 HbC window (RT 3.78 min) |
|
0.3 ± 0.14 |
| 13 |
HbQ India with α |
1 |
1.7 |
3.8 |
22.3 P07 |
12.7 P012 |
1.3 |
| 14 |
HbD Iran Heterozygous |
4 |
0.67 ± 0.15 |
1.45 ± 0.48 |
35.35 ± 1.8 HbE (2.69 min) |
|
0.425 ± 0.26 |
| 15 |
HbH |
1 |
1.2 |
0.9 |
7.1 P00 (RT 0.13 min) |
|
0.8 |
| 16 |
Unknown α variant |
1 |
1.1 |
1.9 |
15.7 P04 (RT 1.27 min) |
|
0.8 |
| 17 |
Hb Lepore trait |
1 |
1.4 |
2.2 |
7.6 P08 (RT 2.67 min) |
|
2.1 |
| 18 |
Normal |
100 |
0.41 ± 0.56 |
2.53 ± 0.3 |
|
|
0.45 ± 0.59 |